| Trial ID: | L5256 |
| Source ID: | NCT02755064
|
| Associated Drug: |
Erythromycin Lactobionate
|
| Title: |
Relationship Between Gastric Emptying and Glycemic Variability in Type 1 Diabetes Mellitus
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 1
|
| Interventions: |
DRUG: Erythromycin lactobionate|DRUG: Placebo IV|DRUG: [13C]-Spirulina|DRUG: Erythromycin Ethylsuccinate Suspension|DRUG: Placebo Suspension
|
| Outcome Measures: |
Primary: Relationship between gastric emptying and glycemia, GE was measured by 13C spirulina GEBT. Glycemia was measured with continuous glucose monitoring., 11 days | Secondary: Number of subjects with delayed gastric emptying, 11 days
|
| Sponsor/Collaborators: |
Sponsor: Adil Bharucha
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
30
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2010-06
|
| Completion Date: |
2013-11
|
| Results First Posted: |
|
| Last Update Posted: |
2016-04-28
|
| Locations: |
Mayo Clinic, Rochester, Minnesota, 55905, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT02755064
|
